← Back to headlines
Mineralys Therapeutics Reports Q4 GAAP EPS Beat
Mineralys Therapeutics announced a GAAP EPS of -$0.40 for the fourth quarter, beating analyst estimates by $0.13.
12 Mar, 20:36 — 12 Mar, 20:36
Sources
Showing 1 of 1 sources
Related Stories
S&P 500 Breaks Major Support, Further Decline Expected
29m ago
Financial Stocks Hit by Private-Credit Panic and Rising Bond Yields
38m ago
HSBC makes bold GCC prediction as Iran vs US-Israel war rattles markets and oil prices surge
54m ago
Investment Strategies Amid U.S.-Iran Conflict Identify Buying Opportunities
58m ago